Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies
Giovanni Musso, Maurizio Cassader, Roberto Gambino
Nature Reviews Drug Discovery (2016) Vol. 15, Iss. 4, pp. 249-274
Closed Access | Times Cited: 382

Showing 1-25 of 382 citing articles:

Pyroptosis: mechanisms and diseases
Pian Yu, Xu Zhang, Nian Liu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1577
Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives
Juan Pablo Arab, Saul J. Karpen, Paul A. Dawson, et al.
Hepatology (2016) Vol. 65, Iss. 1, pp. 350-362
Open Access | Times Cited: 528
Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
Juan Pablo Arab, Marco Arrese, Michael Trauner
Annual Review of Pathology Mechanisms of Disease (2018) Vol. 13, Iss. 1, pp. 321-350
Open Access | Times Cited: 483
Metformin and Its Benefits for Various Diseases
Ziquan Lv, Yajie Guo
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 425
Non-alcoholic fatty liver disease
Brent A. Neuschwander‐Tetri
BMC Medicine (2017) Vol. 15, Iss. 1
Open Access | Times Cited: 416
Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis
Giovanni Musso, Maurizio Cassader, Elena Paschetta, et al.
JAMA Internal Medicine (2017) Vol. 177, Iss. 5, pp. 633-633
Open Access | Times Cited: 375
Role of Oxidative Stress in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Implications for Prevention and Therapy
Johanna C. Arroyave-Ospina, Zongmei Wu, Yana Geng, et al.
Antioxidants (2021) Vol. 10, Iss. 2, pp. 174-174
Open Access | Times Cited: 358
Niche-Specific Reprogramming of Epigenetic Landscapes Drives Myeloid Cell Diversity in Nonalcoholic Steatohepatitis
Jason S. Seidman, Ty D. Troutman, Mashito Sakai, et al.
Immunity (2020) Vol. 52, Iss. 6, pp. 1057-1074.e7
Open Access | Times Cited: 331
Bioactive Lipid Species and Metabolic Pathways in Progression and Resolution of Nonalcoholic Steatohepatitis
Giovanni Musso, Maurizio Cassader, Elena Paschetta, et al.
Gastroenterology (2018) Vol. 155, Iss. 2, pp. 282-302.e8
Open Access | Times Cited: 272
The ménage à trois of autophagy, lipid droplets and liver disease
Yasmina Filali-Mouncef, Catherine J. Hunter, Federica Roccio, et al.
Autophagy (2021) Vol. 18, Iss. 1, pp. 50-72
Open Access | Times Cited: 229
Mouse models of nonalcoholic steatohepatitis in preclinical drug development
Henrik H. Hansen, Michael Feigh, Sanne Skovgård Veidal, et al.
Drug Discovery Today (2017) Vol. 22, Iss. 11, pp. 1707-1718
Open Access | Times Cited: 218
Targeting ferroptosis alleviates methionine‐choline deficient (MCD)‐diet induced NASH by suppressing liver lipotoxicity
Xiaoya Li, Tianxiang Wang, Xinmei Huang, et al.
Liver International (2020) Vol. 40, Iss. 6, pp. 1378-1394
Closed Access | Times Cited: 207
Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates
Pi‐Xiao Wang, Yan‐Xiao Ji, Xiao‐Jing Zhang, et al.
Nature Medicine (2017) Vol. 23, Iss. 4, pp. 439-449
Closed Access | Times Cited: 204
Hepatocyte-derived extracellular vesicles promote endothelial inflammation and atherogenesis via microRNA-1
Fangjie Jiang, Qi Chen, Wei Wang, et al.
Journal of Hepatology (2019) Vol. 72, Iss. 1, pp. 156-166
Closed Access | Times Cited: 189
Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition
Soo Hyun Kim, Gyuri Kim, Dai Hoon Han, et al.
Autophagy (2017) Vol. 13, Iss. 10, pp. 1767-1781
Open Access | Times Cited: 187
Matrix metalloproteinases and liver fibrosis (translational aspects)
Elke Roeb
Matrix Biology (2017) Vol. 68-69, pp. 463-473
Open Access | Times Cited: 184
Therapeutic Landscape for NAFLD in 2020
Brent A. Neuschwander‐Tetri
Gastroenterology (2020) Vol. 158, Iss. 7, pp. 1984-1998.e3
Closed Access | Times Cited: 168
SQSTM1/p62 activates NFE2L2/NRF2 via ULK1-mediated autophagic KEAP1 degradation and protects mouse liver from lipotoxicity
Da Hyun Lee, Jeong Su Park, Yu Seol Lee, et al.
Autophagy (2020) Vol. 16, Iss. 11, pp. 1949-1973
Open Access | Times Cited: 163
TREM2 sustains macrophage-hepatocyte metabolic coordination in nonalcoholic fatty liver disease and sepsis
Jinchao Hou, Jue Zhang, Ping Cui, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 4
Open Access | Times Cited: 162
Immunological mechanisms and therapeutic targets of fatty liver diseases
Hua Wang, Wajahat Z. Mehal, Laura E. Nagy, et al.
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 1, pp. 73-91
Open Access | Times Cited: 157
New targets for NAFLD
Lucia Parlati, Marion Régnier, Hervé Guillou, et al.
JHEP Reports (2021) Vol. 3, Iss. 6, pp. 100346-100346
Open Access | Times Cited: 127
RG-I pectin-like polysaccharide from Rosa chinensis inhibits inflammation and fibrosis associated to HMGB1/TLR4/NF-κB signaling pathway to improve non-alcoholic steatohepatitis
Xiaoqi Jing, G. Y. Zhou, Anming Zhu, et al.
Carbohydrate Polymers (2024) Vol. 337, pp. 122139-122139
Closed Access | Times Cited: 20
Lipopolysaccharide binding protein resists hepatic oxidative stress by regulating lipid droplet homeostasis
Qilun Zhang, Xuting Shen, Xin Yuan, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 18
Hepatic sphingomyelin phosphodiesterase 3 promotes steatohepatitis by disrupting membrane sphingolipid metabolism
Jie Jiang, Yuqing Gao, Jiang Wang, et al.
Cell Metabolism (2025)
Closed Access | Times Cited: 3
Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver Diseases
Yao Yu, Jingjing Cai, Zhi‐Gang She, et al.
Advanced Science (2018) Vol. 6, Iss. 4
Open Access | Times Cited: 153
Page 1 - Next Page

Scroll to top